Characterization of the HDAC/PI3K inhibitor CUDC-907 as a novel senolytic.

MLA

Al-Mansour, Fares, et al. “Characterization of the HDAC/PI3K Inhibitor CUDC-907 as a Novel Senolytic.” Aging, vol. 15, no. 7, Mar. 2023, pp. 2373–94. EBSCOhost, https://doi.org/10.18632/aging.204616.

APA

Al-Mansour, F., Alraddadi, A., He, B., Saleh, A., Poblocka, M., Alzahrani, W., Cowley, S., & Macip, S. (2023). Characterization of the HDAC/PI3K inhibitor CUDC-907 as a novel senolytic. Aging, 15(7), 2373–2394. https://doi.org/10.18632/aging.204616

Chicago

Al-Mansour, Fares, Abdullah Alraddadi, Buwei He, Anes Saleh, Marta Poblocka, Wael Alzahrani, Shaun Cowley, and Salvador Macip. 2023. “Characterization of the HDAC/PI3K Inhibitor CUDC-907 as a Novel Senolytic.” Aging 15 (7): 2373–94. doi:10.18632/aging.204616.